Contact Us

Remicade
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you started taking this drug:

Date you stopped taking this drug:

Why was Remicade prescribed? (arthritis, crohn's disease, etc.)

If Demyelination was diagnosed while taking Remicade, please describe diagnosis:

Was Lymphoma diagnosed after taking Remicade?

Was Tuberculosis (TB) diagnosed after taking Remicade?

If yes, was Tuberculosis ever diagnosed before Remicade?

Were the following side effects a problem while taking Remicade?











Please further describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


$19.4M awarded in J&J drug case

Dec 14, 2006 | Asbury Park Press

Johnson & Johnson's Centocor Inc. unit hid the side effects of its Remicade drug and must pay a woman with lupus symptoms $19.4 million, a Texas jury decided Wednesday.

Patricia Hamilton, 47, began taking Remicade for her Crohn's disease in December 2001 and developed drug-induced lupus the following year, she said in her lawsuit. The drug also left her with increased risk of liver failure, said her attorney.

Hamilton sued Centocor, claiming the company failed to warn doctors of the risks of the drug. A Corpus Christi jury awarded about $3.4 million in actual damages and $16 million in punitive damages. The verdict is the first ever involving Remicade, Johnson & Johnson's second-largest drug by sales.


Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo